2.1. Development of Curcumin Solid Lipid Nanoparticles (CSLNs)

SS Simarjot Kaur Sandhu
SK Suneel Kumar
JR Jayant Raut
MS Mandeep Singh
SK Sandeep Kaur
GS Garima Sharma
TR Tomas L. Roldan
ST Sonia Trehan
JH Jennifer Holloway
GW Gabriella Wahler
JL Jeffrey D. Laskin
PS Patrick J. Sinko
FB Francois Berthiaume
BM Bozena Michniak-Kohn
PR Praveen Rishi
NG Narayanan Ganesh
IK Indu Pal Kaur
ask Ask a question
Favorite

The CSLNs were prepared by a hot high-pressure homogenization method. The curcumin (0.6% w/w in the final formulation) was dissolved in polyethylene glycol (PEG) 600 followed by the addition of molten Compritol® 888 ATO. A primary crude emulsion was prepared by emulsifying this hot lipid phase with the aqueous surfactant phase containing Tween 80 and Phospholipon 90G (soya lecithin), maintained at a temperature 5–10 °C above the melting point of Compritol® 888 ATO (70 °C to 75 °C) using a high-speed stirrer (WiseTis HD 15D, Am Bildacker 16, 97877 Wertheim, Germany) at 8000 rpm for 8 min. The coarse emulsion was subjected to high-pressure homogenization (HPH) using the Emulsiflex C3 Avestin (2450, Don Reid Dr. Ottawa, ON, Canada) homogenizer at 1000 bars and three cycles. The dispersion obtained was allowed to cool to room temperature, forming lipid nanoparticles by re-crystallization of the hot dispersed lipid.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A